Wave Life Sciences
WVE
102 hedge funds and large institutions have $215M invested in Wave Life Sciences in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 24 closing their positions.
55% more call options, than puts
Call options by funds: $7.75M | Put options by funds: $4.99M
4.13% more ownership
Funds ownership: 74% → 78.13% (+4.1%)
9% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 34
6% less funds holding
Funds holding: 108 → 102 (-6)
24% less capital invested
Capital invested by funds: $284M → $215M (-$69.3M)
25% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$33.7M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
+$29.6M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.16M |
| 4 |
Primecap Management
Pasadena,
California
|
+$7.12M |
| 5 |
ACM
Altium Capital Management
New York
|
+$3.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$19.7M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.07M |
| 3 |
Morgan Stanley
New York
|
-$7.06M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$4.56M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.44M |
WVE Hedge Fund Activity: Q1 2021 in Review
102 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2021, worth a combined $215M — down 24% from $284M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of WVE and 18 opened new positions — a net loss of 6 holders — while 34 trimmed existing stakes and 31 added.
The largest buyer was Deerfield Management, opening a new position worth an estimated $33.7M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $19.7M sold.
- 102 institutional investors held Wave Life Sciences (WVE) as of Q1 2021, down from 108 in Q4 2020.
- Funds reported $215M of Wave Life Sciences stock for Q1 2021, down 24% quarter-over-quarter.
- 18 funds opened new Wave Life Sciences positions in Q1 2021 and 24 closed out, a net change of -6 holders.
- The largest Wave Life Sciences buyer in Q1 2021 was Deerfield Management, an estimated $33.7M added.
- The largest Wave Life Sciences seller in Q1 2021 was Perceptive Advisors, an estimated $19.7M sold.
Based on aggregated 13F filings for Q1 2021.